X4 Pharmaceuticals (XFOR) Debt Ratio (2017 - 2023)

X4 Pharmaceuticals has reported Debt Ratio for 6 years, with the latest figure at 0.0 in Q2 2023.

• For the quarter ending Q2 2023, Debt Ratio fell 95.85% year-over-year to 0.0; the trailing twelve-month figure through Jun 2023 stood at 0.0 (down 95.85% YoY), and the FY2022 full-year result was 0.01, up 24.57% from the prior year.
• Debt Ratio for Q2 2023 stood at 0.0, down from 0.0 in the prior quarter.
• The five-year high for Debt Ratio was 0.2 in Q2 2019, with the low at 0.0 in Q2 2023.
• Historically, Debt Ratio has averaged 0.06 across 4 years, with a median of 0.02 in 2022.
• Annual changes were most pronounced in 2022 — Debt Ratio jumped 2142.11% — and 2023, when it slumped 95.85%.
• X4 Pharmaceuticals' Debt Ratio stood at 0.2 in 2019, then plunged by 96.56% to 0.01 in 2021, then climbed by 24.57% to 0.01 in 2022, then plunged by 47.87% to 0.0 in 2023.
• The last three Debt Ratio figures came in at 0.0 (Q2 2023), 0.0 (Q1 2023), and 0.01 (Q4 2022), per Business Quant data.